Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients
Abstract Mutational analysis of circulating tumour (ct) DNA holds promise as an effective tool to predict the course of metastatic breast cancer (MBC). In the present study we used targeted next generation sequencing of ctDNA to evaluate the impact of cancer driven mutations on the prognosis of MBC....
Guardado en:
Autores principales: | Axel Muendlein, Kathrin Geiger, Stella Gaenger, Tobias Dechow, Christoph Nonnenbroich, Andreas Leiherer, Heinz Drexel, Andreas Gaumann, Wolfgang Jagla, Thomas Winder, Frank Mayer, Thomas Decker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37dd500e40fe4840b82c9e036d120298 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis.
por: Kathrin Geiger, et al.
Publicado: (2011) -
Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis.
por: Axel Muendlein, et al.
Publicado: (2011) -
Characterising the phenotypic evolution of circulating tumour cells during treatment
por: Simon Chang-Hao Tsao, et al.
Publicado: (2018) -
Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery
por: Vladimir Anikin, et al.
Publicado: (2021) -
Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer
por: Yan-jun Lu, et al.
Publicado: (2017)